Systemic Therapy in Hepatocellular Carcinoma
Systemic therapy of advanced stage hepatocellular carcinoma (HCC) was limited to the sorafenib in the past decade since 2007. Novel agents including multiple targeting agents, immune checkpoint inhibitors and anti-angiogenesis reported efficacy in treatment. This is the first time, the combination o...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/78669 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Systemic Therapy in Hepatocellular Carcinoma
- Targeted Therapies for Hepatocellular Carcinoma Treatment
- Hepatocellular Carcinoma: Locoregional Therapies and Multidisciplinary Strategies
- Therapy of Hepatocellular Carcinoma with Iodine-131-Lipidiol
- Image-Guided Therapies for Hepatocellular Carcinoma in Hepatocelluar Carcinoma — Future Outlook
- Hepatocellular Carcinoma and Antiviral Therapies in HCV Chronic Infection
- Recent Advancements in Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma